nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNV1—renal system—kidney cancer	0.0119	0.0857	CbGeAlD
Dalfampridine—KCNV1—kidney—kidney cancer	0.0115	0.0829	CbGeAlD
Dalfampridine—KCND1—gonad—kidney cancer	0.00716	0.0516	CbGeAlD
Dalfampridine—KCNS3—nephron tubule—kidney cancer	0.00658	0.0474	CbGeAlD
Dalfampridine—KCNF1—cortex of kidney—kidney cancer	0.00643	0.0464	CbGeAlD
Dalfampridine—KCNA5—renal system—kidney cancer	0.00611	0.044	CbGeAlD
Dalfampridine—KCNH6—nephron tubule—kidney cancer	0.00601	0.0433	CbGeAlD
Dalfampridine—KCNS3—renal system—kidney cancer	0.00599	0.0431	CbGeAlD
Dalfampridine—KCNA5—kidney—kidney cancer	0.00591	0.0426	CbGeAlD
Dalfampridine—KCNS3—kidney—kidney cancer	0.00579	0.0417	CbGeAlD
Dalfampridine—KCNA5—gonad—kidney cancer	0.00548	0.0395	CbGeAlD
Dalfampridine—KCNA5—cardiac atrium—kidney cancer	0.00547	0.0394	CbGeAlD
Dalfampridine—KCNH6—renal system—kidney cancer	0.00546	0.0394	CbGeAlD
Dalfampridine—CYP2E1—urine—kidney cancer	0.00528	0.0381	CbGeAlD
Dalfampridine—KCNH6—kidney—kidney cancer	0.00528	0.0381	CbGeAlD
Dalfampridine—KCNQ2—gonad—kidney cancer	0.00494	0.0356	CbGeAlD
Dalfampridine—KCNQ1—renal system—kidney cancer	0.0044	0.0317	CbGeAlD
Dalfampridine—KCND3—cortex of kidney—kidney cancer	0.00428	0.0309	CbGeAlD
Dalfampridine—KCNQ1—kidney—kidney cancer	0.00426	0.0307	CbGeAlD
Dalfampridine—KCNQ1—cortex of kidney—kidney cancer	0.00415	0.0299	CbGeAlD
Dalfampridine—KCND3—cardiac atrium—kidney cancer	0.00407	0.0293	CbGeAlD
Dalfampridine—KCNQ1—cardiac atrium—kidney cancer	0.00394	0.0284	CbGeAlD
Dalfampridine—KCNH2—renal system—kidney cancer	0.00168	0.0121	CbGeAlD
Dalfampridine—KCNH2—cardiac atrium—kidney cancer	0.0015	0.0108	CbGeAlD
Dalfampridine—CYP2E1—nephron tubule—kidney cancer	0.00142	0.0102	CbGeAlD
Dalfampridine—Skin disorder—Erlotinib—kidney cancer	0.00142	0.00315	CcSEcCtD
Dalfampridine—Angioedema—Sunitinib—kidney cancer	0.00142	0.00314	CcSEcCtD
Dalfampridine—Hypotension—Everolimus—kidney cancer	0.00142	0.00314	CcSEcCtD
Dalfampridine—Connective tissue disorder—Gemcitabine—kidney cancer	0.00141	0.00311	CcSEcCtD
Dalfampridine—Asthenia—Pazopanib—kidney cancer	0.00138	0.00305	CcSEcCtD
Dalfampridine—Insomnia—Everolimus—kidney cancer	0.00137	0.00304	CcSEcCtD
Dalfampridine—Angiopathy—Vincristine—kidney cancer	0.00137	0.00303	CcSEcCtD
Dalfampridine—Paraesthesia—Vinblastine—kidney cancer	0.00137	0.00303	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00136	0.00302	CcSEcCtD
Dalfampridine—Paraesthesia—Everolimus—kidney cancer	0.00136	0.00301	CcSEcCtD
Dalfampridine—Mediastinal disorder—Vincristine—kidney cancer	0.00136	0.00301	CcSEcCtD
Dalfampridine—Dyspnoea—Everolimus—kidney cancer	0.00135	0.00299	CcSEcCtD
Dalfampridine—Dizziness—Temsirolimus—kidney cancer	0.00135	0.00298	CcSEcCtD
Dalfampridine—Convulsion—Sunitinib—kidney cancer	0.00134	0.00298	CcSEcCtD
Dalfampridine—Dyspepsia—Everolimus—kidney cancer	0.00133	0.00295	CcSEcCtD
Dalfampridine—Infestation NOS—Paclitaxel—kidney cancer	0.00133	0.00295	CcSEcCtD
Dalfampridine—Infestation—Paclitaxel—kidney cancer	0.00133	0.00295	CcSEcCtD
Dalfampridine—Insomnia—Erlotinib—kidney cancer	0.00132	0.00293	CcSEcCtD
Dalfampridine—Chest pain—Sunitinib—kidney cancer	0.00132	0.00292	CcSEcCtD
Dalfampridine—Mental disorder—Vincristine—kidney cancer	0.00132	0.00292	CcSEcCtD
Dalfampridine—Anaphylactic shock—Sorafenib—kidney cancer	0.00132	0.00291	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00131	0.0029	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Everolimus—kidney cancer	0.00131	0.0029	CcSEcCtD
Dalfampridine—Infection—Sorafenib—kidney cancer	0.00131	0.00289	CcSEcCtD
Dalfampridine—Dyspnoea—Erlotinib—kidney cancer	0.0013	0.00289	CcSEcCtD
Dalfampridine—Constipation—Vinblastine—kidney cancer	0.0013	0.00288	CcSEcCtD
Dalfampridine—Angiopathy—Gemcitabine—kidney cancer	0.0013	0.00287	CcSEcCtD
Dalfampridine—Urinary tract infection—Paclitaxel—kidney cancer	0.0013	0.00287	CcSEcCtD
Dalfampridine—Constipation—Everolimus—kidney cancer	0.0013	0.00287	CcSEcCtD
Dalfampridine—Vomiting—Temsirolimus—kidney cancer	0.0013	0.00287	CcSEcCtD
Dalfampridine—CYP2E1—renal system—kidney cancer	0.00129	0.00932	CbGeAlD
Dalfampridine—Immune system disorder—Gemcitabine—kidney cancer	0.00129	0.00286	CcSEcCtD
Dalfampridine—Nervous system disorder—Sorafenib—kidney cancer	0.00129	0.00286	CcSEcCtD
Dalfampridine—Mediastinal disorder—Gemcitabine—kidney cancer	0.00129	0.00285	CcSEcCtD
Dalfampridine—Dyspepsia—Erlotinib—kidney cancer	0.00129	0.00285	CcSEcCtD
Dalfampridine—Rash—Temsirolimus—kidney cancer	0.00129	0.00284	CcSEcCtD
Dalfampridine—Dermatitis—Temsirolimus—kidney cancer	0.00128	0.00284	CcSEcCtD
Dalfampridine—Skin disorder—Sorafenib—kidney cancer	0.00128	0.00283	CcSEcCtD
Dalfampridine—Headache—Temsirolimus—kidney cancer	0.00128	0.00283	CcSEcCtD
Dalfampridine—Nasopharyngitis—Capecitabine—kidney cancer	0.00127	0.00281	CcSEcCtD
Dalfampridine—Dizziness—Pazopanib—kidney cancer	0.00127	0.00281	CcSEcCtD
Dalfampridine—Back pain—Vincristine—kidney cancer	0.00127	0.00281	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00126	0.0028	CcSEcCtD
Dalfampridine—Infection—Sunitinib—kidney cancer	0.00126	0.00278	CcSEcCtD
Dalfampridine—Feeling abnormal—Vinblastine—kidney cancer	0.00125	0.00278	CcSEcCtD
Dalfampridine—Constipation—Erlotinib—kidney cancer	0.00125	0.00277	CcSEcCtD
Dalfampridine—CYP2E1—kidney—kidney cancer	0.00125	0.00901	CbGeAlD
Dalfampridine—Feeling abnormal—Everolimus—kidney cancer	0.00125	0.00277	CcSEcCtD
Dalfampridine—Nervous system disorder—Sunitinib—kidney cancer	0.00124	0.00275	CcSEcCtD
Dalfampridine—Skin disorder—Sunitinib—kidney cancer	0.00123	0.00272	CcSEcCtD
Dalfampridine—Vomiting—Pazopanib—kidney cancer	0.00122	0.0027	CcSEcCtD
Dalfampridine—CYP2E1—cortex of kidney—kidney cancer	0.00122	0.00877	CbGeAlD
Dalfampridine—Rash—Pazopanib—kidney cancer	0.00121	0.00268	CcSEcCtD
Dalfampridine—Nausea—Temsirolimus—kidney cancer	0.00121	0.00268	CcSEcCtD
Dalfampridine—Dermatitis—Pazopanib—kidney cancer	0.00121	0.00268	CcSEcCtD
Dalfampridine—Back pain—Gemcitabine—kidney cancer	0.0012	0.00267	CcSEcCtD
Dalfampridine—Headache—Pazopanib—kidney cancer	0.0012	0.00266	CcSEcCtD
Dalfampridine—Infection—Dactinomycin—kidney cancer	0.00119	0.00264	CcSEcCtD
Dalfampridine—Connective tissue disorder—Paclitaxel—kidney cancer	0.00118	0.0026	CcSEcCtD
Dalfampridine—Dyspnoea—Sorafenib—kidney cancer	0.00117	0.0026	CcSEcCtD
Dalfampridine—Dyspepsia—Sorafenib—kidney cancer	0.00116	0.00256	CcSEcCtD
Dalfampridine—Insomnia—Sunitinib—kidney cancer	0.00115	0.00254	CcSEcCtD
Dalfampridine—Nausea—Pazopanib—kidney cancer	0.00114	0.00252	CcSEcCtD
Dalfampridine—Paraesthesia—Sunitinib—kidney cancer	0.00114	0.00252	CcSEcCtD
Dalfampridine—Convulsion—Vincristine—kidney cancer	0.00114	0.00252	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00114	0.00252	CcSEcCtD
Dalfampridine—Dyspnoea—Sunitinib—kidney cancer	0.00113	0.0025	CcSEcCtD
Dalfampridine—Constipation—Sorafenib—kidney cancer	0.00113	0.00249	CcSEcCtD
Dalfampridine—Hypersensitivity—Vinblastine—kidney cancer	0.00112	0.00248	CcSEcCtD
Dalfampridine—Hypersensitivity—Everolimus—kidney cancer	0.00112	0.00247	CcSEcCtD
Dalfampridine—Dyspepsia—Sunitinib—kidney cancer	0.00112	0.00247	CcSEcCtD
Dalfampridine—Infestation NOS—Capecitabine—kidney cancer	0.00109	0.00242	CcSEcCtD
Dalfampridine—Infestation—Capecitabine—kidney cancer	0.00109	0.00242	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00109	0.00242	CcSEcCtD
Dalfampridine—Asthenia—Vinblastine—kidney cancer	0.00109	0.00242	CcSEcCtD
Dalfampridine—Asthenia—Everolimus—kidney cancer	0.00109	0.00241	CcSEcCtD
Dalfampridine—Angiopathy—Paclitaxel—kidney cancer	0.00109	0.0024	CcSEcCtD
Dalfampridine—Constipation—Sunitinib—kidney cancer	0.00108	0.0024	CcSEcCtD
Dalfampridine—Immune system disorder—Paclitaxel—kidney cancer	0.00108	0.00239	CcSEcCtD
Dalfampridine—Mediastinal disorder—Paclitaxel—kidney cancer	0.00108	0.00239	CcSEcCtD
Dalfampridine—Anaphylactic shock—Vincristine—kidney cancer	0.00107	0.00237	CcSEcCtD
Dalfampridine—Infection—Vincristine—kidney cancer	0.00106	0.00236	CcSEcCtD
Dalfampridine—Urinary tract infection—Capecitabine—kidney cancer	0.00106	0.00236	CcSEcCtD
Dalfampridine—Chest pain—Gemcitabine—kidney cancer	0.00106	0.00235	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00105	0.00233	CcSEcCtD
Dalfampridine—Nervous system disorder—Vincristine—kidney cancer	0.00105	0.00233	CcSEcCtD
Dalfampridine—Asthenia—Erlotinib—kidney cancer	0.00105	0.00232	CcSEcCtD
Dalfampridine—Mental disorder—Paclitaxel—kidney cancer	0.00105	0.00232	CcSEcCtD
Dalfampridine—Urticaria—Sorafenib—kidney cancer	0.00105	0.00231	CcSEcCtD
Dalfampridine—Anaphylactic shock—Gemcitabine—kidney cancer	0.00102	0.00225	CcSEcCtD
Dalfampridine—Infection—Gemcitabine—kidney cancer	0.00101	0.00223	CcSEcCtD
Dalfampridine—Back pain—Paclitaxel—kidney cancer	0.00101	0.00223	CcSEcCtD
Dalfampridine—Dizziness—Vinblastine—kidney cancer	0.00101	0.00223	CcSEcCtD
Dalfampridine—Dizziness—Everolimus—kidney cancer	0.001	0.00222	CcSEcCtD
Dalfampridine—Hypotension—Vincristine—kidney cancer	0.001	0.00222	CcSEcCtD
Dalfampridine—Nervous system disorder—Gemcitabine—kidney cancer	0.000997	0.00221	CcSEcCtD
Dalfampridine—Feeling abnormal—Dactinomycin—kidney cancer	0.000988	0.00219	CcSEcCtD
Dalfampridine—Skin disorder—Gemcitabine—kidney cancer	0.000987	0.00218	CcSEcCtD
Dalfampridine—Tremor—Paclitaxel—kidney cancer	0.000977	0.00216	CcSEcCtD
Dalfampridine—Hypersensitivity—Sorafenib—kidney cancer	0.00097	0.00215	CcSEcCtD
Dalfampridine—Insomnia—Vincristine—kidney cancer	0.000969	0.00214	CcSEcCtD
Dalfampridine—Vomiting—Vinblastine—kidney cancer	0.000968	0.00214	CcSEcCtD
Dalfampridine—Dizziness—Erlotinib—kidney cancer	0.000968	0.00214	CcSEcCtD
Dalfampridine—Connective tissue disorder—Capecitabine—kidney cancer	0.000966	0.00214	CcSEcCtD
Dalfampridine—Vomiting—Everolimus—kidney cancer	0.000964	0.00213	CcSEcCtD
Dalfampridine—Paraesthesia—Vincristine—kidney cancer	0.000962	0.00213	CcSEcCtD
Dalfampridine—Rash—Everolimus—kidney cancer	0.000956	0.00212	CcSEcCtD
Dalfampridine—Dermatitis—Everolimus—kidney cancer	0.000955	0.00211	CcSEcCtD
Dalfampridine—Headache—Vinblastine—kidney cancer	0.000954	0.00211	CcSEcCtD
Dalfampridine—Angioedema—Paclitaxel—kidney cancer	0.000953	0.00211	CcSEcCtD
Dalfampridine—Headache—Everolimus—kidney cancer	0.00095	0.0021	CcSEcCtD
Dalfampridine—Hypotension—Gemcitabine—kidney cancer	0.00095	0.0021	CcSEcCtD
Dalfampridine—Asthenia—Sorafenib—kidney cancer	0.000945	0.00209	CcSEcCtD
Dalfampridine—Hypersensitivity—Sunitinib—kidney cancer	0.000933	0.00207	CcSEcCtD
Dalfampridine—Vomiting—Erlotinib—kidney cancer	0.00093	0.00206	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000925	0.00205	CcSEcCtD
Dalfampridine—Rash—Erlotinib—kidney cancer	0.000923	0.00204	CcSEcCtD
Dalfampridine—Dermatitis—Erlotinib—kidney cancer	0.000922	0.00204	CcSEcCtD
Dalfampridine—Insomnia—Gemcitabine—kidney cancer	0.000919	0.00203	CcSEcCtD
Dalfampridine—Headache—Erlotinib—kidney cancer	0.000917	0.00203	CcSEcCtD
Dalfampridine—Constipation—Vincristine—kidney cancer	0.000916	0.00203	CcSEcCtD
Dalfampridine—Paraesthesia—Gemcitabine—kidney cancer	0.000913	0.00202	CcSEcCtD
Dalfampridine—Asthenia—Sunitinib—kidney cancer	0.000909	0.00201	CcSEcCtD
Dalfampridine—Dyspnoea—Gemcitabine—kidney cancer	0.000906	0.00201	CcSEcCtD
Dalfampridine—Nausea—Vinblastine—kidney cancer	0.000904	0.002	CcSEcCtD
Dalfampridine—Convulsion—Paclitaxel—kidney cancer	0.000903	0.002	CcSEcCtD
Dalfampridine—Nausea—Everolimus—kidney cancer	0.000901	0.00199	CcSEcCtD
Dalfampridine—Angiopathy—Capecitabine—kidney cancer	0.000892	0.00197	CcSEcCtD
Dalfampridine—Immune system disorder—Capecitabine—kidney cancer	0.000888	0.00196	CcSEcCtD
Dalfampridine—Chest pain—Paclitaxel—kidney cancer	0.000888	0.00196	CcSEcCtD
Dalfampridine—Mediastinal disorder—Capecitabine—kidney cancer	0.000886	0.00196	CcSEcCtD
Dalfampridine—Anxiety—Paclitaxel—kidney cancer	0.000885	0.00196	CcSEcCtD
Dalfampridine—Hypersensitivity—Dactinomycin—kidney cancer	0.000884	0.00196	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000882	0.00195	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000878	0.00194	CcSEcCtD
Dalfampridine—Dizziness—Sorafenib—kidney cancer	0.000871	0.00193	CcSEcCtD
Dalfampridine—Constipation—Gemcitabine—kidney cancer	0.000869	0.00192	CcSEcCtD
Dalfampridine—Nausea—Erlotinib—kidney cancer	0.000869	0.00192	CcSEcCtD
Dalfampridine—Mental disorder—Capecitabine—kidney cancer	0.000861	0.00191	CcSEcCtD
Dalfampridine—Asthenia—Dactinomycin—kidney cancer	0.00086	0.0019	CcSEcCtD
Dalfampridine—Confusional state—Paclitaxel—kidney cancer	0.000858	0.0019	CcSEcCtD
Dalfampridine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000851	0.00188	CcSEcCtD
Dalfampridine—Infection—Paclitaxel—kidney cancer	0.000845	0.00187	CcSEcCtD
Dalfampridine—Dizziness—Sunitinib—kidney cancer	0.000838	0.00185	CcSEcCtD
Dalfampridine—Feeling abnormal—Gemcitabine—kidney cancer	0.000838	0.00185	CcSEcCtD
Dalfampridine—Vomiting—Sorafenib—kidney cancer	0.000837	0.00185	CcSEcCtD
Dalfampridine—Nervous system disorder—Paclitaxel—kidney cancer	0.000835	0.00185	CcSEcCtD
Dalfampridine—Rash—Sorafenib—kidney cancer	0.00083	0.00184	CcSEcCtD
Dalfampridine—Dermatitis—Sorafenib—kidney cancer	0.000829	0.00184	CcSEcCtD
Dalfampridine—Back pain—Capecitabine—kidney cancer	0.000828	0.00183	CcSEcCtD
Dalfampridine—Skin disorder—Paclitaxel—kidney cancer	0.000827	0.00183	CcSEcCtD
Dalfampridine—Headache—Sorafenib—kidney cancer	0.000825	0.00183	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000819	0.00181	CcSEcCtD
Dalfampridine—Vomiting—Sunitinib—kidney cancer	0.000805	0.00178	CcSEcCtD
Dalfampridine—Tremor—Capecitabine—kidney cancer	0.000802	0.00177	CcSEcCtD
Dalfampridine—Rash—Sunitinib—kidney cancer	0.000799	0.00177	CcSEcCtD
Dalfampridine—Dermatitis—Sunitinib—kidney cancer	0.000798	0.00177	CcSEcCtD
Dalfampridine—Hypotension—Paclitaxel—kidney cancer	0.000795	0.00176	CcSEcCtD
Dalfampridine—Headache—Sunitinib—kidney cancer	0.000794	0.00176	CcSEcCtD
Dalfampridine—Hypersensitivity—Vincristine—kidney cancer	0.000789	0.00175	CcSEcCtD
Dalfampridine—Nausea—Sorafenib—kidney cancer	0.000782	0.00173	CcSEcCtD
Dalfampridine—Insomnia—Paclitaxel—kidney cancer	0.00077	0.0017	CcSEcCtD
Dalfampridine—Asthenia—Vincristine—kidney cancer	0.000769	0.0017	CcSEcCtD
Dalfampridine—Paraesthesia—Paclitaxel—kidney cancer	0.000764	0.00169	CcSEcCtD
Dalfampridine—Vomiting—Dactinomycin—kidney cancer	0.000762	0.00169	CcSEcCtD
Dalfampridine—Dyspnoea—Paclitaxel—kidney cancer	0.000759	0.00168	CcSEcCtD
Dalfampridine—Rash—Dactinomycin—kidney cancer	0.000756	0.00167	CcSEcCtD
Dalfampridine—Nausea—Sunitinib—kidney cancer	0.000752	0.00167	CcSEcCtD
Dalfampridine—Dyspepsia—Paclitaxel—kidney cancer	0.000749	0.00166	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000735	0.00163	CcSEcCtD
Dalfampridine—Asthenia—Gemcitabine—kidney cancer	0.000729	0.00161	CcSEcCtD
Dalfampridine—Chest pain—Capecitabine—kidney cancer	0.000728	0.00161	CcSEcCtD
Dalfampridine—Constipation—Paclitaxel—kidney cancer	0.000728	0.00161	CcSEcCtD
Dalfampridine—Anxiety—Capecitabine—kidney cancer	0.000726	0.00161	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000723	0.0016	CcSEcCtD
Dalfampridine—Nausea—Dactinomycin—kidney cancer	0.000712	0.00158	CcSEcCtD
Dalfampridine—Dizziness—Vincristine—kidney cancer	0.000709	0.00157	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—kidney cancer	0.000706	0.00156	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—kidney cancer	0.000706	0.00156	CcSEcCtD
Dalfampridine—Confusional state—Capecitabine—kidney cancer	0.000704	0.00156	CcSEcCtD
Dalfampridine—Feeling abnormal—Paclitaxel—kidney cancer	0.000701	0.00155	CcSEcCtD
Dalfampridine—Infection—Capecitabine—kidney cancer	0.000694	0.00154	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—kidney cancer	0.000686	0.00152	CcSEcCtD
Dalfampridine—Nervous system disorder—Capecitabine—kidney cancer	0.000685	0.00152	CcSEcCtD
Dalfampridine—Vomiting—Vincristine—kidney cancer	0.000681	0.00151	CcSEcCtD
Dalfampridine—Skin disorder—Capecitabine—kidney cancer	0.000678	0.0015	CcSEcCtD
Dalfampridine—Urticaria—Paclitaxel—kidney cancer	0.000676	0.0015	CcSEcCtD
Dalfampridine—Rash—Vincristine—kidney cancer	0.000676	0.0015	CcSEcCtD
Dalfampridine—Dermatitis—Vincristine—kidney cancer	0.000675	0.00149	CcSEcCtD
Dalfampridine—Headache—Vincristine—kidney cancer	0.000671	0.00149	CcSEcCtD
Dalfampridine—Hypotension—Capecitabine—kidney cancer	0.000653	0.00144	CcSEcCtD
Dalfampridine—Vomiting—Gemcitabine—kidney cancer	0.000646	0.00143	CcSEcCtD
Dalfampridine—Rash—Gemcitabine—kidney cancer	0.000641	0.00142	CcSEcCtD
Dalfampridine—Dermatitis—Gemcitabine—kidney cancer	0.00064	0.00142	CcSEcCtD
Dalfampridine—Headache—Gemcitabine—kidney cancer	0.000637	0.00141	CcSEcCtD
Dalfampridine—Nausea—Vincristine—kidney cancer	0.000636	0.00141	CcSEcCtD
Dalfampridine—Insomnia—Capecitabine—kidney cancer	0.000632	0.0014	CcSEcCtD
Dalfampridine—Paraesthesia—Capecitabine—kidney cancer	0.000627	0.00139	CcSEcCtD
Dalfampridine—Hypersensitivity—Paclitaxel—kidney cancer	0.000627	0.00139	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—kidney cancer	0.000623	0.00138	CcSEcCtD
Dalfampridine—Dyspnoea—Capecitabine—kidney cancer	0.000623	0.00138	CcSEcCtD
Dalfampridine—Dyspepsia—Capecitabine—kidney cancer	0.000615	0.00136	CcSEcCtD
Dalfampridine—Asthenia—Paclitaxel—kidney cancer	0.000611	0.00135	CcSEcCtD
Dalfampridine—Nausea—Gemcitabine—kidney cancer	0.000604	0.00134	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000603	0.00133	CcSEcCtD
Dalfampridine—Constipation—Capecitabine—kidney cancer	0.000597	0.00132	CcSEcCtD
Dalfampridine—Feeling abnormal—Capecitabine—kidney cancer	0.000575	0.00127	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—kidney cancer	0.000575	0.00127	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—kidney cancer	0.000572	0.00127	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—kidney cancer	0.000571	0.00126	CcSEcCtD
Dalfampridine—Dizziness—Paclitaxel—kidney cancer	0.000563	0.00125	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—kidney cancer	0.000555	0.00123	CcSEcCtD
Dalfampridine—Urticaria—Capecitabine—kidney cancer	0.000555	0.00123	CcSEcCtD
Dalfampridine—Vomiting—Paclitaxel—kidney cancer	0.000541	0.0012	CcSEcCtD
Dalfampridine—Rash—Paclitaxel—kidney cancer	0.000537	0.00119	CcSEcCtD
Dalfampridine—Dermatitis—Paclitaxel—kidney cancer	0.000536	0.00119	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—kidney cancer	0.000534	0.00118	CcSEcCtD
Dalfampridine—Headache—Paclitaxel—kidney cancer	0.000533	0.00118	CcSEcCtD
Dalfampridine—Hypersensitivity—Capecitabine—kidney cancer	0.000515	0.00114	CcSEcCtD
Dalfampridine—Nausea—Paclitaxel—kidney cancer	0.000505	0.00112	CcSEcCtD
Dalfampridine—Asthenia—Capecitabine—kidney cancer	0.000501	0.00111	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—kidney cancer	0.000478	0.00106	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—kidney cancer	0.00047	0.00104	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—kidney cancer	0.000468	0.00104	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000466	0.00103	CcSEcCtD
Dalfampridine—Dizziness—Capecitabine—kidney cancer	0.000462	0.00102	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—kidney cancer	0.000454	0.001	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—kidney cancer	0.00045	0.000996	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—kidney cancer	0.000447	0.00099	CcSEcCtD
Dalfampridine—Vomiting—Capecitabine—kidney cancer	0.000444	0.000983	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—kidney cancer	0.000441	0.000977	CcSEcCtD
Dalfampridine—Rash—Capecitabine—kidney cancer	0.00044	0.000974	CcSEcCtD
Dalfampridine—Dermatitis—Capecitabine—kidney cancer	0.00044	0.000974	CcSEcCtD
Dalfampridine—Headache—Capecitabine—kidney cancer	0.000437	0.000968	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—kidney cancer	0.000437	0.000968	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—kidney cancer	0.000421	0.000931	CcSEcCtD
Dalfampridine—Nausea—Capecitabine—kidney cancer	0.000415	0.000918	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—kidney cancer	0.000407	0.000901	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—kidney cancer	0.000404	0.000895	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—kidney cancer	0.000401	0.000888	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—kidney cancer	0.000396	0.000877	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000389	0.00086	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—kidney cancer	0.000385	0.000852	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—kidney cancer	0.000371	0.000821	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—kidney cancer	0.000358	0.000791	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—kidney cancer	0.000332	0.000734	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—kidney cancer	0.000323	0.000715	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—kidney cancer	0.000298	0.000659	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—kidney cancer	0.000286	0.000633	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—kidney cancer	0.000284	0.000628	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—kidney cancer	0.000284	0.000628	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—kidney cancer	0.000282	0.000624	CcSEcCtD
Dalfampridine—KCNS3—Metabolism—LDHB—kidney cancer	0.000275	0.000671	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—LDHB—kidney cancer	0.000275	0.000671	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000269	0.000657	CbGpPWpGaD
Dalfampridine—Nausea—Doxorubicin—kidney cancer	0.000267	0.000592	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000266	0.000651	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC5A3—kidney cancer	0.000266	0.000649	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PGK1—kidney cancer	0.000266	0.000649	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PAX6—kidney cancer	0.000265	0.000647	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PAX6—kidney cancer	0.000265	0.000647	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—BRAF—kidney cancer	0.000263	0.000642	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—BRAF—kidney cancer	0.000263	0.000642	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—MAPK1—kidney cancer	0.000263	0.000642	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—MAPK1—kidney cancer	0.000263	0.000642	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—LDHB—kidney cancer	0.000261	0.000636	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—BRAF—kidney cancer	0.000258	0.00063	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000257	0.000629	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—RAF1—kidney cancer	0.000253	0.000619	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—RAF1—kidney cancer	0.000253	0.000619	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—RAF1—kidney cancer	0.000253	0.000619	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP1A1—kidney cancer	0.000253	0.000618	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—JUN—kidney cancer	0.000249	0.000608	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—ALDH1A1—kidney cancer	0.000248	0.000607	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—RAF1—kidney cancer	0.000246	0.000602	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—MAPK1—kidney cancer	0.000244	0.000595	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—PTEN—kidney cancer	0.000241	0.000588	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—RAF1—kidney cancer	0.00024	0.000586	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CA9—kidney cancer	0.000238	0.000582	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CA9—kidney cancer	0.000238	0.000582	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CA9—kidney cancer	0.000238	0.000582	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—BRAF—kidney cancer	0.000233	0.00057	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—BRAF—kidney cancer	0.00023	0.000561	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PAK1—kidney cancer	0.00023	0.000561	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PAK1—kidney cancer	0.00023	0.000561	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CA9—kidney cancer	0.000226	0.000552	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—RAF1—kidney cancer	0.00022	0.000536	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—RAF1—kidney cancer	0.00022	0.000536	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—ACHE—kidney cancer	0.000219	0.000535	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—JUN—kidney cancer	0.000218	0.000532	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—MAPK1—kidney cancer	0.000217	0.000531	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—RAF1—kidney cancer	0.000215	0.000526	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—PTEN—kidney cancer	0.00021	0.000514	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—MAPK1—kidney cancer	0.000207	0.000506	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—MAPK1—kidney cancer	0.000207	0.000506	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000205	0.0005	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CRABP1—kidney cancer	0.000203	0.000495	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CRABP1—kidney cancer	0.000203	0.000495	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CRABP1—kidney cancer	0.000203	0.000495	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000202	0.000493	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KDR—kidney cancer	0.0002	0.000489	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KDR—kidney cancer	0.0002	0.000489	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MET—kidney cancer	0.000196	0.000479	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—kidney cancer	0.000196	0.000479	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—BRAF—kidney cancer	0.000195	0.000477	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—BRAF—kidney cancer	0.000195	0.000477	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—RAF1—kidney cancer	0.000195	0.000476	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CRABP1—kidney cancer	0.000192	0.000469	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—RAF1—kidney cancer	0.000192	0.000469	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BCHE—kidney cancer	0.000191	0.000466	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ITPR2—kidney cancer	0.000188	0.00046	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ITPR2—kidney cancer	0.000188	0.00046	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ITPR2—kidney cancer	0.000188	0.00046	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000187	0.000457	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ITPR2—kidney cancer	0.000179	0.000436	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—MAPK1—kidney cancer	0.000174	0.000424	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—MAPK1—kidney cancer	0.000174	0.000424	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—MAPK1—kidney cancer	0.000174	0.000424	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTT1—kidney cancer	0.000172	0.00042	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ACHE—kidney cancer	0.000172	0.00042	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTT1—kidney cancer	0.000172	0.00042	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTT1—kidney cancer	0.000172	0.00042	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ACHE—kidney cancer	0.000172	0.00042	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ACHE—kidney cancer	0.000172	0.00042	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—MAPK1—kidney cancer	0.000169	0.000413	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000166	0.000405	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—MAPK1—kidney cancer	0.000165	0.000402	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—kidney cancer	0.000164	0.000401	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—RAF1—kidney cancer	0.000163	0.000399	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—RAF1—kidney cancer	0.000163	0.000399	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTT1—kidney cancer	0.000163	0.000398	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ACHE—kidney cancer	0.000163	0.000398	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SCARB1—kidney cancer	0.000163	0.000397	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SCARB1—kidney cancer	0.000163	0.000397	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SCARB1—kidney cancer	0.000163	0.000397	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS1—kidney cancer	0.000161	0.000393	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS1—kidney cancer	0.000161	0.000393	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS1—kidney cancer	0.000161	0.000393	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PSMD7—kidney cancer	0.000158	0.000386	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PSMD7—kidney cancer	0.000158	0.000386	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PSMD7—kidney cancer	0.000158	0.000386	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SCARB1—kidney cancer	0.000154	0.000377	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS1—kidney cancer	0.000153	0.000373	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000153	0.000373	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MAPK1—kidney cancer	0.000151	0.000368	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—MAPK1—kidney cancer	0.000151	0.000368	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PSMD7—kidney cancer	0.00015	0.000366	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—BCHE—kidney cancer	0.00015	0.000366	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—BCHE—kidney cancer	0.00015	0.000366	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—BCHE—kidney cancer	0.00015	0.000366	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC5A5—kidney cancer	0.000148	0.000361	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC5A5—kidney cancer	0.000148	0.000361	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC5A5—kidney cancer	0.000148	0.000361	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—MAPK1—kidney cancer	0.000148	0.000361	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTT1—kidney cancer	0.000146	0.000356	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—RAF1—kidney cancer	0.000145	0.000354	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—RAF1—kidney cancer	0.000145	0.000354	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—kidney cancer	0.000144	0.000351	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—kidney cancer	0.000143	0.00035	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—kidney cancer	0.000143	0.00035	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KDR—kidney cancer	0.000143	0.000349	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—kidney cancer	0.000143	0.000349	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SLC2A1—kidney cancer	0.000143	0.000349	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SLC2A1—kidney cancer	0.000143	0.000349	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SLC2A1—kidney cancer	0.000143	0.000349	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—BCHE—kidney cancer	0.000142	0.000347	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC5A5—kidney cancer	0.00014	0.000342	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—kidney cancer	0.00014	0.000342	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—kidney cancer	0.00014	0.000342	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—PTGS1—kidney cancer	0.000137	0.000334	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SLC2A1—kidney cancer	0.000135	0.000331	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MAPK1—kidney cancer	0.000134	0.000326	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MAPK1—kidney cancer	0.000132	0.000322	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000124	0.000302	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—kidney cancer	0.000119	0.000291	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—kidney cancer	0.000119	0.000291	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—kidney cancer	0.000119	0.000291	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—kidney cancer	0.000113	0.000276	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000113	0.000276	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—kidney cancer	0.000113	0.000275	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—kidney cancer	0.000113	0.000275	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—kidney cancer	0.000113	0.000275	CbGpPWpGaD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.000113	0.000275	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000112	0.000274	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MAPK1—kidney cancer	0.000112	0.000273	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MAPK1—kidney cancer	0.000112	0.000273	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—kidney cancer	0.00011	0.000269	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—kidney cancer	0.00011	0.000269	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—kidney cancer	0.000109	0.000267	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—kidney cancer	0.000109	0.000267	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—kidney cancer	0.000109	0.000267	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—kidney cancer	0.000107	0.000261	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK3—kidney cancer	0.000104	0.000255	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK3—kidney cancer	0.000104	0.000255	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—kidney cancer	0.000104	0.000253	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A1—kidney cancer	0.000104	0.000253	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1A1—kidney cancer	0.000104	0.000253	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A1—kidney cancer	0.000104	0.000253	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RAF1—kidney cancer	0.000103	0.000252	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RAF1—kidney cancer	0.000103	0.000252	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RELA—kidney cancer	0.000103	0.000251	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RELA—kidney cancer	0.000103	0.000251	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—kidney cancer	0.000102	0.00025	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—kidney cancer	0.000102	0.00025	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—kidney cancer	0.000101	0.000247	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—kidney cancer	9.98e-05	0.000244	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK1—kidney cancer	9.93e-05	0.000243	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK1—kidney cancer	9.93e-05	0.000243	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	9.86e-05	0.000241	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A1—kidney cancer	9.83e-05	0.00024	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—kidney cancer	9.73e-05	0.000238	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—kidney cancer	9.38e-05	0.000229	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—kidney cancer	9.38e-05	0.000229	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—kidney cancer	9.3e-05	0.000227	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—kidney cancer	9.17e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—kidney cancer	8.94e-05	0.000218	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—kidney cancer	8.94e-05	0.000218	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A1—kidney cancer	8.81e-05	0.000215	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A1—kidney cancer	8.69e-05	0.000212	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—RAF1—kidney cancer	8.12e-05	0.000198	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—kidney cancer	7.87e-05	0.000192	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—kidney cancer	7.87e-05	0.000192	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACY1—kidney cancer	7.75e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—POMC—kidney cancer	7.73e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—POMC—kidney cancer	7.73e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—POMC—kidney cancer	7.73e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK3—kidney cancer	7.45e-05	0.000182	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK3—kidney cancer	7.45e-05	0.000182	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—POMC—kidney cancer	7.33e-05	0.000179	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK1—kidney cancer	7.09e-05	0.000173	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK1—kidney cancer	7.09e-05	0.000173	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—kidney cancer	6.69e-05	0.000163	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—kidney cancer	6.69e-05	0.000163	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PDHB—kidney cancer	6.59e-05	0.000161	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—POMC—kidney cancer	6.57e-05	0.00016	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CCBL1—kidney cancer	6.2e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—kidney cancer	6.17e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—kidney cancer	6.17e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—kidney cancer	6.17e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—kidney cancer	5.85e-05	0.000143	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MAPK1—kidney cancer	5.57e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—kidney cancer	5.38e-05	0.000131	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—kidney cancer	5.38e-05	0.000131	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—kidney cancer	5.38e-05	0.000131	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GLIPR1—kidney cancer	5.37e-05	0.000131	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPAT—kidney cancer	5.37e-05	0.000131	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—kidney cancer	5.1e-05	0.000125	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FH—kidney cancer	4.99e-05	0.000122	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APRT—kidney cancer	4.99e-05	0.000122	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPC3—kidney cancer	4.7e-05	0.000115	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA2—kidney cancer	4.57e-05	0.000112	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALAD—kidney cancer	4.45e-05	0.000109	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ST3GAL2—kidney cancer	4.35e-05	0.000106	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDH1A1—kidney cancer	4.25e-05	0.000104	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PGK1—kidney cancer	4.07e-05	9.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A3—kidney cancer	4.07e-05	9.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LDHB—kidney cancer	3.99e-05	9.75e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—kidney cancer	3.79e-05	9.27e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—kidney cancer	3.79e-05	9.27e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—kidney cancer	3.79e-05	9.27e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—kidney cancer	3.6e-05	8.79e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA9—kidney cancer	3.46e-05	8.46e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CRABP1—kidney cancer	2.94e-05	7.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ITPR2—kidney cancer	2.74e-05	6.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—kidney cancer	2.5e-05	6.1e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACHE—kidney cancer	2.5e-05	6.1e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SCARB1—kidney cancer	2.36e-05	5.77e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS1—kidney cancer	2.34e-05	5.71e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PSMD7—kidney cancer	2.29e-05	5.6e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BCHE—kidney cancer	2.17e-05	5.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A5—kidney cancer	2.15e-05	5.25e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A1—kidney cancer	2.07e-05	5.07e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—kidney cancer	1.73e-05	4.23e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—kidney cancer	1.64e-05	4e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—kidney cancer	1.59e-05	3.88e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.51e-05	3.68e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—POMC—kidney cancer	1.12e-05	2.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—kidney cancer	8.96e-06	2.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—kidney cancer	7.82e-06	1.91e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—kidney cancer	5.51e-06	1.35e-05	CbGpPWpGaD
